Logo image of BLBD

BLUE BIRD CORP (BLBD) Stock Fundamental Analysis

USA - NASDAQ:BLBD - US0953061068 - Common Stock

53.63 USD
-0.3 (-0.56%)
Last: 10/6/2025, 12:05:02 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BLBD. BLBD was compared to 129 industry peers in the Machinery industry. BLBD has only an average score on both its financial health and profitability. BLBD is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make BLBD suitable for value investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

BLBD had positive earnings in the past year.
BLBD had a positive operating cash flow in the past year.
In multiple years BLBD reported negative net income over the last 5 years.
In multiple years BLBD reported negative operating cash flow during the last 5 years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 20.14%, BLBD belongs to the top of the industry, outperforming 98.45% of the companies in the same industry.
The Return On Equity of BLBD (52.24%) is better than 98.45% of its industry peers.
The Return On Invested Capital of BLBD (28.56%) is better than 99.22% of its industry peers.
Industry RankSector Rank
ROA 20.14%
ROE 52.24%
ROIC 28.56%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

BLBD's Profit Margin of 8.16% is fine compared to the rest of the industry. BLBD outperforms 64.34% of its industry peers.
BLBD's Profit Margin has improved in the last couple of years.
BLBD has a Operating Margin (10.02%) which is in line with its industry peers.
In the last couple of years the Operating Margin of BLBD has grown nicely.
BLBD has a worse Gross Margin (19.47%) than 73.64% of its industry peers.
BLBD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.02%
PM (TTM) 8.16%
GM 19.47%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

6

2. Health

2.1 Basic Checks

BLBD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
BLBD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BLBD has been increased compared to 5 years ago.
Compared to 1 year ago, BLBD has an improved debt to assets ratio.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

BLBD has an Altman-Z score of 6.59. This indicates that BLBD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.59, BLBD belongs to the top of the industry, outperforming 86.82% of the companies in the same industry.
BLBD has a debt to FCF ratio of 0.64. This is a very positive value and a sign of high solvency as it would only need 0.64 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.64, BLBD belongs to the best of the industry, outperforming 89.15% of the companies in the same industry.
A Debt/Equity ratio of 0.39 indicates that BLBD is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.39, BLBD perfoms like the industry average, outperforming 58.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 0.64
Altman-Z 6.59
ROIC/WACC2.95
WACC9.67%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

A Current Ratio of 1.58 indicates that BLBD should not have too much problems paying its short term obligations.
The Current ratio of BLBD (1.58) is worse than 71.32% of its industry peers.
A Quick Ratio of 0.92 indicates that BLBD may have some problems paying its short term obligations.
BLBD's Quick ratio of 0.92 is on the low side compared to the rest of the industry. BLBD is outperformed by 69.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.92
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

BLBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.95%, which is quite good.
Measured over the past years, BLBD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.38% on average per year.
BLBD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.31%.
The Revenue has been growing slightly by 5.74% on average over the past years.
EPS 1Y (TTM)13.95%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%30.77%
Revenue 1Y (TTM)9.31%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%19.39%

3.2 Future

Based on estimates for the next years, BLBD will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.19% on average per year.
BLBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.74% yearly.
EPS Next Y19.98%
EPS Next 2Y12%
EPS Next 3Y11.19%
EPS Next 5YN/A
Revenue Next Year9.46%
Revenue Next 2Y6.83%
Revenue Next 3Y7.31%
Revenue Next 5Y6.74%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.97 indicates a correct valuation of BLBD.
BLBD's Price/Earnings ratio is rather cheap when compared to the industry. BLBD is cheaper than 87.60% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.86. BLBD is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 12.29 indicates a correct valuation of BLBD.
Based on the Price/Forward Earnings ratio, BLBD is valued cheaper than 89.92% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.32. BLBD is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.97
Fwd PE 12.29
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

78.29% of the companies in the same industry are more expensive than BLBD, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BLBD indicates a rather cheap valuation: BLBD is cheaper than 91.47% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.88
EV/EBITDA 10.31
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BLBD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.7
PEG (5Y)0.85
EPS Next 2Y12%
EPS Next 3Y11.19%

More info and screens

0

5. Dividend

5.1 Amount

BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUE BIRD CORP

NASDAQ:BLBD (10/6/2025, 12:05:02 PM)

53.63

-0.3 (-0.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-24 2025-11-24/amc
Inst Owners113.37%
Inst Owner Change0%
Ins Owners0.54%
Ins Owner Change-7.4%
Market Cap1.70B
Analysts82.86
Price Target60.31 (12.46%)
Short Float %14.16%
Short Ratio7.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.14%
Min EPS beat(2)-0.8%
Max EPS beat(2)21.07%
EPS beat(4)3
Avg EPS beat(4)11.51%
Min EPS beat(4)-0.8%
Max EPS beat(4)21.07%
EPS beat(8)7
Avg EPS beat(8)46.57%
EPS beat(12)10
Avg EPS beat(12)-86.96%
EPS beat(16)11
Avg EPS beat(16)-81.93%
Revenue beat(2)1
Avg Revenue beat(2)1.19%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)3.33%
Revenue beat(4)2
Avg Revenue beat(4)1.51%
Min Revenue beat(4)-0.95%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)4.34%
Revenue beat(12)9
Avg Revenue beat(12)6.43%
Revenue beat(16)11
Avg Revenue beat(16)6.25%
PT rev (1m)4.51%
PT rev (3m)14.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.57%
EPS NY rev (1m)0.7%
EPS NY rev (3m)7.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.06%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 13.97
Fwd PE 12.29
P/S 1.2
P/FCF 11.88
P/OCF 10.22
P/B 7.67
P/tB 10.57
EV/EBITDA 10.31
EPS(TTM)3.84
EY7.16%
EPS(NY)4.37
Fwd EY8.14%
FCF(TTM)4.51
FCFY8.42%
OCF(TTM)5.25
OCFY9.79%
SpS44.81
BVpS7
TBVpS5.07
PEG (NY)0.7
PEG (5Y)0.85
Profitability
Industry RankSector Rank
ROA 20.14%
ROE 52.24%
ROCE 41.05%
ROIC 28.56%
ROICexc 56.99%
ROICexgc 87.8%
OM 10.02%
PM (TTM) 8.16%
GM 19.47%
FCFM 10.07%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y220.13%
ROICexcg growth 5Y10.5%
ROICexc growth 3Y207.87%
ROICexc growth 5Y19.73%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
F-Score7
Asset Turnover2.47
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 0.64
Debt/EBITDA 0.55
Cap/Depr 149.83%
Cap/Sales 1.64%
Interest Coverage 13.04
Cash Conversion 105.36%
Profit Quality 123.49%
Current Ratio 1.58
Quick Ratio 0.92
Altman-Z 6.59
F-Score7
WACC9.67%
ROIC/WACC2.95
Cap/Depr(3y)67.41%
Cap/Depr(5y)84.95%
Cap/Sales(3y)0.9%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.95%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%30.77%
EPS Next Y19.98%
EPS Next 2Y12%
EPS Next 3Y11.19%
EPS Next 5YN/A
Revenue 1Y (TTM)9.31%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%19.39%
Revenue Next Year9.46%
Revenue Next 2Y6.83%
Revenue Next 3Y7.31%
Revenue Next 5Y6.74%
EBIT growth 1Y-0.36%
EBIT growth 3Y177.79%
EBIT growth 5Y26.04%
EBIT Next Year45.81%
EBIT Next 3Y18.59%
EBIT Next 5Y13.76%
FCF growth 1Y34.94%
FCF growth 3YN/A
FCF growth 5Y36.54%
OCF growth 1Y45.83%
OCF growth 3YN/A
OCF growth 5Y14.81%